Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Dequalinium→

Dequalinium Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
522-51-0
Molecular formula
C30H40N4+2
Molecular weight
456.7 g/mol
Drug class
Quaternary ammonium antiseptictopical/local anti-infective agent
Mechanism of action
A surface-active antiseptic that increases microbial cell-membrane permeability, causing loss of enzyme activity and cell death. It exhibits rapid local bactericidal activity.
Indications / reported uses
  • Local treatment of bacterial vaginosis with the 10 mg vaginal tablet formulation; do not extrapolate this indication to other dequalinium salts or dosage forms

Sources: UK SmPC — Fluomizin 10 mg vaginal tablets · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Dequalinium Environmental Risk Assessment (ERA) (the Dequalinium ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.